Alessandro Zuddas Award for Child and Adolescent Neuropsychopharmacology

This award recognises excellent research in the treatment and prevention of disorders of the brain for children and adolescents, including preclinical research, and clinical science, and evidence-based approaches to prevention.

The award is given annually, based on the abstract submitted for poster presentation at the ECNP Congress. 

The award comes with a cash prize of EUR 500 and is conferred at the ECNP Congress.

Winner 2025

The recipient is Lisa Geertjens, the Netherlands, for her poster PS03-2159 on 'Individual bumetanide responses on patient-reported-outcomes-measures measuring sensory reactivity in children with neurodevelopmental disorders: a multiple baseline single-case experimental design'.

More info

Award ceremony

The award will be presented at the 38th ECNP Congress during the closing ceremony. 

Who is eligible?

All poster presenters at the ECNP Congress are eligible to win the award.

How to apply

If your abstract involves research in child and adolescent neuropsychopharmacology and is accepted - and you present your poster at the ECNP Congress - you will automatically be applying for the ECNP Alessandro Zuddas Award in Child and Adolescent Neuropsychopharmacology.

Selection of the awardees

The winning abstract will be selected by members of the ECNP Child and Adolescent Neuropsychopharmacology Network. Their choice will be based on the scientific excellence of the research and its potential relevance to the discovery and/or development of new treatments.

Previous winner

Year Winner Poster
2024

Jesus Camacho
Spain

P1172
Meta-analyses on the prevalence of negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis